HeartSciences Inc Warrant
HSCSW
4 hedge funds and large institutions have $35.3K invested in HeartSciences Inc Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
9% more capital invested
Capital invested by funds: $32.4K → $35.3K (+$2.84K)
0.09% less ownership
Funds ownership: 6.08% → 6% (-0.09%)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$1.53K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$52 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$63 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$3 |
HSCSW Hedge Fund Activity: Q4 2023 in Review
4 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q4 2023, worth a combined $35.3K — up 8.8% from $32.4K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of HSCSW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $1.53K. The largest seller was UBS Group, exiting entirely with an estimated $63 sold.
- 4 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q4 2023, down from 5 in Q3 2023.
- Funds reported $35.3K of HeartSciences Inc Warrant stock for Q4 2023, up 8.8% quarter-over-quarter.
- 1 fund opened new HeartSciences Inc Warrant positions in Q4 2023 and 2 closed out, a net change of -1 holder.
- The largest HeartSciences Inc Warrant buyer in Q4 2023 was Virtu Financial, an estimated $1.53K added.
- The largest HeartSciences Inc Warrant seller in Q4 2023 was UBS Group, an estimated $63 sold.
Based on aggregated 13F filings for Q4 2023.